IDH突变型胶质瘤的MR影像表型与全基因组拷贝数丰度范围相关
本研究回顾18例WHO II-IV级IDH突变型星形细胞瘤的术前MRI与Illumina 850k EPIC DNA甲基化阵列衍生的拷贝数变异图,按拷贝数变异稳定性分组(CNV-S≤3个染色体获得/缺失且无局灶基因扩增;CNV-U>3个大染色体获得/缺失和/或局灶扩增),评估MR特征、rCBV与拷贝数丰度及进展时间的关系。CNV-U肿瘤平均肿瘤大小和FLAIR最大径更大(均P=0.004),中位rCBV更高(2.62 vs 0.78,P=0.019),进展时间有缩短趋势但无统计学显著性(P=0.393)。
要点
- IDH突变型星形细胞瘤中CNV-U组较CNV-S组FLAIR最大径更大(P=0.004)。
- CNV-U组中位rCBV为2.62,高于CNV-S组的0.78(P=0.019)。
- CNV-U组进展时间有缩短趋势,但无统计学显著性(P=0.393)。
核心结论
- 较大的肿瘤大小/直径和较高的rCBV与CNV-U型星形细胞瘤相关,提示IDH突变型星形细胞瘤中侵袭性影像表型与不稳定且侵袭性的基因型存在相关性。
研究设计与样本
- 回顾性分析18例WHO II-IV级IDH突变型星形细胞瘤的术前MRI及Illumina 850k EPIC DNA甲基化阵列衍生的拷贝数变异图,按拷贝数变异稳定性分为CNV-S组(≤3个染色体获得或缺失且无局灶基因扩增)和CNV-U组(>3个大染色体获得/缺失和/或局灶扩增),评估MR特征、rCBV、拷贝数丰度与进展时间的关系。
关键影像表现/征象
- CNV-U肿瘤平均肿瘤大小较CNV-S更大(P=0.004)。
- CNV-U肿瘤FLAIR最大径较CNV-S更大(P=0.004)。
- CNV-U肿瘤中位rCBV为2.62,CNV-S为0.78(P=0.019)。
诊断标准与关键数值
- CNV-S定义为≤3个染色体获得或缺失且无局灶基因扩增(9例,50%)。
- CNV-U定义为>3个大染色体获得/缺失和/或局灶扩增(9例,50%)。
- 肿瘤rCBV通过DSC T2*灌注分析获得。
临床应用与阅片要点
- 在IDH突变型星形细胞瘤阅片时,可关注肿瘤大小、FLAIR最大径及rCBV,这些影像特征与拷贝数不稳定型基因型相关。
- CNV-U组进展时间有缩短趋势但无统计学显著性(P=0.393),原文未据此给出随访或治疗推荐。
局限性
- CNV-U肿瘤进展时间有缩短趋势但无统计学显著性(P=0.393)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: There is variability in survival within IDH mutant gliomas determined by chromosomal events. Copy number variation (CNV) abundance associated with survival in low-grade and IDH mutant astrocytoma has been reported. Our purpose was to correlate the extent of genome-wide CNV abundance in IDH mutant astrocytomas with MRI features.
METHODS: Presurgical MRI and CNV plots derived from Illumina 850k EPIC DNA methylation arrays of 18 cases of WHO grade II-IV IDH mutant astrocytomas were reviewed. IDH mutant astrocytomas were divided into CNV stable group (CNV-S) with ≤ 3 chromosomal gains or losses and lack of focal gene amplifications and CNV unstable group (CNV-U) with > 3 large chromosomal gains/losses and/or focal amplifications. The associations between MR features, relative cerebral blood volume (rCBV), CNV abundance, and time to progression were assessed. Tumor rCBV estimates were obtained using DSC T2* perfusion analysis.
RESULTS: There were nine (50%) CNV-S and nine (50%) CNV-U IDH mutant astrocytomas. CNV-U tumors showed larger mean tumor size (P = 0.004) and maximum diameter on FLAIR (P = 0.004) and also demonstrated significantly higher median rCBV than CNV-S tumors (2.62 vs 0.78, P = 0.019). CNV-U tumors tended to have shorter time to progression although without statistical significance (P = 0.393).
CONCLUSIONS: Larger size/diameter and higher rCBVs were seen associated CNV-U astrocytomas, suggesting a correlation of aggressive imaging phenotype with unstable and aggressive genotype in IDH mutant astrocytomas.
引用
- Wu CC, Jain R, Neto L, et al. MR imaging phenotype correlates with extent of genome-wide copy number abundance in IDH mutant gliomas. Neuroradiology. 2019. PMID: 31134296. doi:10.1007/s00234-019-02219-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。